Summary
The goal of this work was to determine the molecular basis for the induction of tumour vascularization and progression by injury. Magnetic resonance imaging (MRI) studies demonstrated that administration of wound fluid derived from cutaneous injuries in pigs reduced the lag for vascularization and initiation of growth of C6 glioma spheroids, implanted in nude mice, and accelerated tumour doubling time. The former effect can be attributed to the angiogenic capacity of wound fluid as detected in vivo by MRI, and in vitro in promoting endothelial cell proliferation. The latter effect, namely the induced rate of tumour growth, is consistent with the angiogenic activity of wound fluid as well as with the finding that wound fluid was directly mitogenic to the tumour cells, and accelerated growth of C6 glioma in spheroid culture. Of the multiple growth factors present in wound fluid, two key factors, heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) and platelet-derived growth factor (PDGF), were identified as the dominant mitogens for C6 glioma, and inhibition of their activity using specific neutralizing antibodies suppressed the mitogenic effect of wound fluid on DNA synthesis in C6 glioma. This study suggests that the stimulatory effect of injury on tumour progression can possibly be attenuated by therapeutic targeting directed against a limited number of specific growth factors.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abramovitch, R., Meir, G. & Neeman, M. (1995). Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. Cancer Res 55: 1956–1962.
Abramovitch, R., Marikovsky, M., Meir, G. & Neeman, M. (1998a). Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI. Br J Cancer 77: 440–447.
Abramovitch, R., Neeman, M., Reich, R., Stein, I., Keshet, E., Abraham, J., Solomon, A. & Marikovsky, M. (1998b). Intercellular communication between vascular smooth muscle and endothelial cells mediated by HB-EGF and VEGF. FEBS Lett 425: 441–447.
Abramovitch, R., Frenkiel, D. & Neeman, M. (1998c). Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 39: 813–824.
Bogden, A. E., Moreau, J. P. & Eden, P. A. (1997). Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer 75: 1021–1027.
Deelman, H. T. (1927). The part played by injury and repair in the development of cancer. Br Med J 1: 872
Dvorak, H. F., Brown, L. F., Detmar, M. & Dvorak, A. M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029–1039.
Frank, S., Hubner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G. & Werner, S. (1995). Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270: 12607–12613.
Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C. & Klagsbrun, M. (1991). A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251: 936–939.
Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A. & Schlessinger, J. (1985). Amplification and overexpression of the EGF receptor gene in primary human glioblastomas. Cell Sci 3(suppl): 161–172.
Lynch, S. E. (1991). Interactions of growth factors in tissue repair. Prog Clin Biol Res 365: 341–357.
Marikovsky, M., Breuing, K., Liu, P. Y., Eriksson, E., Higashiyama, S., Farber, P., Abraham, J. & Klagsbrun, M. (1993). Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 90: 3889–3893.
Marikovsky, M., Vogt, P., Eriksson, E., Rubin, J. S., Taylor, W. G., Joachim, S. & Klagsbrun, M. (1996). Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation. J Invest Dermatol 106: 616–621.
Moulin, V. (1995). Growth factors in skin wound healing. Eur J Cell Biol 68: 1–7.
Murthy, S. M., Goldschmidt, R. A., Rao, L. N., Ammirati, M., Buchmann, T. & Scanlon, E. F. (1989). The influence of surgical trauma on experimental metastasis. Cancer 64: 2035–2044.
Murthy, M. S., Summaria, L. J., Miller, R. J., Wyse, T. B., Goldschmidt, R. A. & Scanlon, E. F. (1991). Inhibition of tumor implantation at sites of trauma by plasminogen activators. Cancer 68: 1724–1730.
O’Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. & Folkman, J. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315–328.
O’Reilly, M. S., Holmgren, L., Chen, C. & Folkman, J. (1996). Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 2: 689–692.
Pedersen, P. H., Ness, G. O., Engebraaten, O., Bjerkvig, R., Lillehaug, J. R. & Laerum, O. D. (1994). Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion. Int J Cancer 56: 255–261.
Peoples, G. E., Blotnick, S., Takahashi, K., Freeman, M. R., Klagsbrun, M. & Eberlein, T. J. (1995). T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc Natl Acad Sci USA 92: 6547–6251.
Pollack, I. F., Randall, M. S., Kristofik, M. P., Kelly, R. H., Selker, R. G. & Vertosick, F. T. Jr (1991). Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. J Neurosurg 75: 284–293.
Schiffenbauer, Y. S., Abramovitch, R., Meir, G., Nevo, N., Holzinger, M., Itin, A., Keshet, E. & Neeman, M. (1997). Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 94: 13203–13208.
Strawn, L. M., Mann, E., Elliger, S. S., Chu, L. M., Germain, L. L., Niederfellner, G., Ullrich, A. & Shawver, L. K. (1994). Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor. J Biol Chem 269: 21215–21222.
Tsai, J. C., Goldman, C. K. & Gillespie, G. Y. (1995). Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82: 864–873.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Abramovitch, R., Marikovsky, M., Meir, G. et al. Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 79, 1392–1398 (1999). https://doi.org/10.1038/sj.bjc.6690223
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690223
Keywords
This article is cited by
-
Anesthesia and cancer recurrence: an overview
Journal of Anesthesia, Analgesia and Critical Care (2022)
-
Application of an instructive hydrogel accelerates re-epithelialization of xenografted human skin wounds
Scientific Reports (2022)
-
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
Journal of Ovarian Research (2021)
-
Stress and cancer: mechanisms, significance and future directions
Nature Reviews Cancer (2021)
-
Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model
Journal of Ovarian Research (2018)